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Sir,
Colistin in combination with other agents is indicated as a last
resort agent for the treatment of severe infections caused by
multiple-drug resistant gram-negative bacteria, particularly those
resistant to carbapenems. Worryingly, the recent emergence and
global dissemination of the plasmid-mediated resistance gene
mcr-1, which encodes a phosphoethanolamine transferase, threat-
ens to render treatment with polymyxins ineffective [1]. This
scenario has been further complicated by the presence in
Enterobacteriaceae of incompatibility (Inc) type plasmids such
as IncFII, IncX4, IncHI2A, and IncI2, able to carry genes encoding
extended-spectrum beta-lactamases (ESBL) and carbapenemases
together with mcr-1 gene [1].
Although colistin resistance attributed to mcr genes have been
reported in E. coli isolates recovered from broiler farms, poultry,
and birds in the bird-market in the state of Qatar [2], these genes
have seldom been found in human specimen [3]. An E. coli isolate
MS8345 (ST95) having mcr-1 borne on an IncHI2 plasmid was
reported from a patient with a subarachnoid hemorrhage and was
resistant to multiple antibiotics [3]. Herein, we report two
multidrug-resistant E. coli strains carrying mcr-1 gene along with
blaCTX-M and blaNDM genes recovered from rectal swabs of pediatric
patients during their routine admission screening for multidrug-
resistant organisms to the Intensive Care Unit. Both isolates are
part of our collection of ESBL-producing Enterobacteriaceae
submitted for molecular typing and antimicrobial resistance genes
characterization. The isolates have been inoculated onto two
selective chromogenic media: CHROMagarTM ESBL and CHROMa-
garTM mSuperCARBA (CHROMagar, France) in the Microbiology
laboratory and identified using the MALDI TOF Biotyper system
(Bruker, Bremen, Germany). Antimicrobial susceptibility testing
was performed using the BD PhoenixTM identification and
susceptibility testing system (Becton Dickinson, USA). Minimum
inhibitory concentrations (MIC) for colistin was determined by
broth microdilution (ComASPTM Colistin, Liofilchem, Italy). MICs
were interpreted according to the CLSI breakpoints. Whole genome
sequencing was performed, and the sequence data was analyzed
(For detailed information, see the supplementary text).
Colistin resistance in CP9 was attributed to the mcr-1 located on
a contig (27149 bp) that shared > 99% identity and > 98% coverage
to many plasmids of different E. coli during BLAST search to NCBI
databases; one of them was recognized as a IncI2 plasmid pBA76-
MCR-1 (64942 bp, GenBank accession no. KX013540) harbored by ahttp://dx.doi.org/10.1016/j.jgar.2020.06.029
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NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).mcr-1-positive E. coli in Bahrain. The contig had the same
architecture to pBA76-MCR-1 while mcr-1 was located in between
the relaxase and DNA topoisomerase III (Fig.1). The isolate had also
high-level resistance to carbapenems owing to the production of
NDM-1 enzyme; annotation of the contig (6944 bp) carrying
blaNDM-1 revealed the presence of insertional sequences ISAba14
and ISAba125 as well as bleomycin ble(MBL) located upstream and
downstream of blaNDM-1 respectively [4]. The contig carrying
blaNDM-1 also was co-localized with the aminoglycoside-modifying
enzyme gene aph(30)-VI. Genomics analysis identified other
resistance genes conferring resistance to β-lactams (blaCTX-M-15,
blaTEM-1A, blaOXA-9), aminoglycosides (aac(60)-Ib, aadA1, aph(30')-Ib,
aph(30)-VI, aph(6)-Id), sulfonamides/trimethoprim (sul2 and
dfrA14), and tetracyclines [tet(A)] (supplementary Table 1). Isolate
CP9 belongs to ST115 and phylogenetic group A, which has been
commensal and commonly detected in animals, livestock, poultry
(43.3%) from Europe and United States and in five human cases
from Denmark, Germany, Sri Lanka and Ecuador according to the
MLST database (http://enterobase.warwick.ac.uk/species/index/
ecoli).
The mcr-1 gene in isolate E192 was found on a 61169 bp contig
with an IncI2 replicon (revealed by Plasmidfinder); the contig was
>99% identical to plasmids of at least five E. coli samples during
BLAST search. Similar to the genetic organization of pk19EC149
(GenBank accession no. CP050290.1), the mcr-1 gene was also
located between relaxase and DNA topoisomerase III (Fig. 1).
Analysis of the genome sequence confirmed the presence of
multiple genes associated with resistance to β -lactams (blaCTX-M-
15, blaTEM-141), aminoglycosides (ant(20')-Ia, aadA1), fosfomycin
(fosA3), trimethoprim-sulfaamethoxazole (sul1, sul2 and dfrA1),
chloramphenicol (floR), and tetracyclines [tet(A)]. In addition, E. coli
E192 displayed resistance to ciprofloxacin (MIC > 2 mg/L) owing to
a single amino acid substitution in ParC topoisomerase IV (S80I)
and double amino acid substitutions in DNA gyrase A (S83 L and
D87 N) that are related to high-level fluoroquinolone resistance
(supplementary Table 1). This isolate corresponds to ST540 and
phylogenetic group D, which has been commonly reported in food
and environmental sources (34%) according to the MLST database
(http://enterobase.warwick.ac.uk/species/index/ecoli); isolates of
human origin were also reported in various countries in Europe
and the United States.
In terms of antibiotic stewardship, One Health Approach
acknowledges human and animal health as one single intercon-
nected unity in a particular environment. The presence of these
two STs in animal and the environment could indicate the spread
and dissemination of plasmid-mediated mcr-1 from the environ-
mental and animal sources to humans in local environment [1,5].
Independently of the source, the co-carriage of mcr-1 and blaNDM-1
in E. coli clinical isolate possess an alarming challenge for
antimicrobial stewardship programs in health care facilities iniety for Antimicrobial Chemotherapy. This is an open access article under the CC BY-
Fig. 1. The mcr-1–containing contigs from E. coli CP9 and E192 isolated from pediatric patients compared to pk19EC149 plasmid (CP050290.1). BRIG was used to generate a
visual representation of the CP9 and E192 (27149 bp and 60864 bp contigs) assembled to pk19EC149. Coding regions of pk19EC149 are represented in the inner ring; the mcr-
1–containing contigs are represented in the outer rings. Green and black arrows represent the major well annotated genes in the outer ring.
Letter to the Editor / Journal of Global Antimicrobial Resistance 22 (2020) 662–663 663Qatar. Routine colistin testing for Enterobacteriaceae should be
part of a coordinated approach to prevent the proliferation of
bacteria harboring a plasmid with mcr-1 and the carbapenemase.
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